SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Nanotechnology for COVID-19: Therapeutics and Vaccine Research. - Abstract - Europe PMC
COVID-19 vaccine development and a potential nanomaterial path forward | Nature Nanotechnology
Moderna Therapeutics — Wikipédia
Moderna's coronavirus vaccine shows encouraging early results - The Washington Post
Current Status of COVID‐19 (Pre)Clinical Vaccine Development - Ye - 2020 - Angewandte Chemie International Edition - Wiley Online Library
PDF) mRNA vaccines — a new era in vaccinology
COVID-19 tracker: Regeneron's antibody cocktail hit by safety concerns; Novo's Rybelsus emerging from pandemic slump | FiercePharma
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
Michael J. Hogan's research works | The Children's Hospital of Philadelphia, PA (CHOP) and other places
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery - ScienceDirect
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Frontiers | Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections | Immunology
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
PDF) Generating an Anti-HIV Vaccine Using Nucleoside-modified mRNA Encoding Envelope
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
PDF) Modified mRNA Vaccines Protect against Zika Virus Infection
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery - ScienceDirect
Crowd fund launched for 'Battlestar Galactica' actor Michael Hogan after brain injury
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
